Overactive Bladder Treatment Market

1
MarketsandMarkets Presents

• Overactive Bladder Treatment Market
• - Global Forecast to 2022

2

• The global overactive bladder treatment market is
  projected to reach USD 4.19 Billion by 2022 from
  USD 3.63 Billion in 2017, at a CAGR of 2.9. The
  growth of this market is majorly driven by the
  increasing geriatric population and consequently
  rising prevalence of bladder overactivity,
  aggressive marketing strategies by pharma
  companies, and the development of new therapies
  to treat bladder overactivity. However, the
  undesired systemic effects caused by
  anticholinergics may hinder the growth of the
  market to a certain extent.
• Therapy approvals are regulated by various
  regional regulatory authorities. The changing
  regulatory scenario favoring overactive bladder
  treatments in a number of countries, such as the
  U.K. and Japan, will offer significant growth
  opportunities for market players. For example,
  the U.K.s National Institutes for Health and
  Care Excellence (NICE) reimburses the BOTOX
  therapy. In 2007, the Japanese Ministry of
  Health, Labour and Welfare (MHLW) launched an
  action plan to promote the safe use of generics.

3
http//www.marketsandmarkets.com/Market-Repor
ts/overactive-bladder-treatment-market-219938791.h
tml The report analyzes the overactive bladder
treatment market by pharmacotherapy, disease
type, and region. On the basis of
pharmacotherapy, the anticholinergics segment
accounted for the largest share in 2016, being
the first line of medical treatment on bladder
overactivity. Based on disease type, the
idiopathic overactive bladder treatment segment
accounted for the largest share in 2016. The high
share of this segment can be attributed to its
high prevalence women are more susceptible to
the condition owing to bladder muscle weakness
post pregnancy and menopause.
4

• Geographically, the global overactive bladder
  treatment market is segmented into the U.S.,
  Europe, Asia-Pacific, and the Rest of the World.
  In 2016, the U.S. dominated the market and this
  is primarily attributed to its well-established
  healthcare industry with favorable reimbursement
  of overactive bladder treatment, growing
  prevalence of the disease with rising age, and
  the presence of major players. The Rest of
  Asia-Pacific region is expected to witness the
  highest CAGR during the forecast period owing to
  rising prevalence of bladder overactivity,
  increasing geriatric population, rising
  healthcare expenditure, and growing awareness on
  overactive bladder.
• In 2016, Astellas Pharma, Inc. (Japan) and
  Pfizer, Inc. (U.S.) dominated the global market.
  Some of the other players competing in this
  market are Teva Pharmaceutical Industries Limited
  (Israel), Allergan, Plc (Ireland), Medtronic plc
  (Ireland), Mylan N.V. (U.S.), Endo International
  Plc (Ireland), Hisamitsu Pharmaceutical Co., Inc.
  (Japan), Sanofi (France), Aurobindo Pharma
  Limited (India), Apotex, Inc. (Canada), and
  Cogentix Medical, Inc. (U.S.).

5
Contact Us

• Mr. RohanMarkets and Markets UNIT no 802, Tower
  no. 7, SEZMagarpatta city, HadapsarPune,
  Maharashtra 411013, India1-888-600-6441Email
  sales_at_marketsandmarkets.com
• MarketsandMarkets Blog
• http//www.linkedin.com/company/marketsandmarkets
• http//twitter.com/marketsmarkets

6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.